The American Gastroenterological Association (AGA) has released an expert review and clinical practice update focusing on esophageal dysfunction caused by immune-mediated and infectious diseases.

Bando et al. perform a phase II trial of atezolizumab monotherapy following platinum-based definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell ...

Information of patients undergoing esophageal cancer surgery in our hospital were collected ... Quantitative data are expressed as mean ± standard deviation or median (range), depending on whether it ...

approval by the U.S. Food and Drug Administration for its redesigned esolution ® esophageal deviation device, has begun its commercial launch starting in the United States. S4 has the first and ...